(Total Views: 365)
Posted On: 10/14/2019 5:11:42 PM
Post# of 153887
I’ve been here since 2015 and purchased some of my shares above the $1 range. Luckily, I didn’t purchase a large number of shares at that point and have gotten my average down to .41 at the moment.
The problem? Like you, everytime I think I can average down and wait for “take off,” the SP continues to drop. Blows my mind as I didn’t think the FDA issues and funding issues would last this long. IMO, the .20s won’t happen unless 1. There’s another dilutive offering and/or 2. The BLA has another delay. God help us if the FDA asks for another requirement because I’m not sure NP nor the SP will survive.
I’m hoping cancer and/or GvHD data is promising and will give a boost to the market cap, but I’m unsure if that data will be available in a timely fashion. Give the delays over the past +12 months, it’s hard to gauge how the next 3-4 will pan out. I want to trust NP, but I understand the FDA is a frustrating government agency and even another 1-2 month delay could cost us shareholders even more dilution.
The problem? Like you, everytime I think I can average down and wait for “take off,” the SP continues to drop. Blows my mind as I didn’t think the FDA issues and funding issues would last this long. IMO, the .20s won’t happen unless 1. There’s another dilutive offering and/or 2. The BLA has another delay. God help us if the FDA asks for another requirement because I’m not sure NP nor the SP will survive.
I’m hoping cancer and/or GvHD data is promising and will give a boost to the market cap, but I’m unsure if that data will be available in a timely fashion. Give the delays over the past +12 months, it’s hard to gauge how the next 3-4 will pan out. I want to trust NP, but I understand the FDA is a frustrating government agency and even another 1-2 month delay could cost us shareholders even more dilution.
(2)
(0)
